augmentation for treating irritability in children and adolescents with autism spectrum
disorders (ASD). Method Forty children and adolescents met diagnostic criteria for ASD
according to DSM-IV. They were randomly allocated into one of the two groups of NAC
(1200 mg/day)+ risperidone or placebo+ risperidone. NAC and placebo were administered
in the form of effervescent and in two divided doses for 8 weeks. Irritability subscale score of …